Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 556

1.

[Vaccination in patients with systemic diseases].

Hanslik T, Niedziolka P, Kernéis S, Launay O; Groupe GEVACCIM.

Presse Med. 2009 Feb;38(2):235-42. doi: 10.1016/j.lpm.2008.10.011. Epub 2008 Nov 28. French.

PMID:
19041215
2.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
3.

Viral hepatitis prevention by immunization.

Ferreira CT, da Silveira TR.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S55-66. Review. Erratum in: J Pediatr (Rio J). 2007 Jan-Feb;83(1):following 97.

4.

[Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].

Tatochenko VK, Il'ina NI, Romanenko VV, Alikova OA, Fassakhov RS, Miasnikova TN, Patlusova VV, Zima IuIu, Reshetnikova ID, Frolova GS, Smolenov IV.

Zh Mikrobiol Epidemiol Immunobiol. 2006 Sep-Oct;(6):30-5. Russian.

PMID:
17163135
5.

Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.

Kumar TS, Abraham P, Raghuraman S, Cherian T.

Indian Pediatr. 2000 Jan;37(1):75-80. No abstract available.

PMID:
10745392
6.

Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.

Ciarlet M, He S, Lai S, Petrecz M, Yuan G, Liu GF, Mikviman E, Heaton PM, Panzer F, Rose T, Koller DY, Van Damme P, Schödel F.

Pediatr Infect Dis J. 2009 Mar;28(3):177-81. doi: 10.1097/INF.0b013e31818c0161.

PMID:
19209092
7.

[Immunization recommendations for travel in the Mediterranean area].

Rendi-Wagner P, Hoeller K, Kollaritsch H; Osterreichische Expertengruppe für Reisemedizin.

Wien Klin Wochenschr. 2004 Oct 30;116(19-20):652-60. German.

PMID:
15941073
8.

Protection against vaccine-preventable diseases in medical students.

Baer G, Bonhoeffer J, Schaad UB, Heininger U.

Pediatr Infect Dis J. 2003 Apr;22(4):373-4. No abstract available.

PMID:
12712970
9.

Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.

Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA; Infectious Diseases Society of America.

Clin Infect Dis. 2009 Sep 15;49(6):817-40. doi: 10.1086/605430. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9):1465.

10.

Systemic adverse effects of hepatitis B vaccines are rare.

[No authors listed]

Prescrire Int. 2004 Dec;13(74):218-23.

PMID:
15612143
11.

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.

Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL.

Vaccine. 2009 Apr 28;27(19):2540-7. doi: 10.1016/j.vaccine.2008.11.115. Epub 2009 Jan 3.

PMID:
19124057
12.

Hepatitis A vaccines.

Shahidah KN.

Med J Malaysia. 2005 Jul;60 Suppl B:112-5. Review.

PMID:
16108190
13.

Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.

Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E.

Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):282-94.

PMID:
19323013
14.

[Vaccination scheme in advanced chronic kidney disease].

Barril G, Teruel JL.

Nefrologia. 2008;28 Suppl 3:95-9. Spanish.

15.

Progress in timely vaccination coverage among children living in low-income households.

Smith PJ, Jain N, Stevenson J, Männikkö N, Molinari NA.

Arch Pediatr Adolesc Med. 2009 May;163(5):462-8. doi: 10.1001/archpediatrics.2009.25.

PMID:
19414693
16.

Vaccination guidelines for female infertility patients.

Practice Committee of American Society for Reproductive Medicine.

Fertil Steril. 2008 Nov;90(5 Suppl):S169-71. doi: 10.1016/j.fertnstert.2008.08.056.

PMID:
19007619
17.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
18.

Why treat? Better prevent: adult immunization.

Kishore PV, Palaian S, Paudel R, Paudel B, Mishra P, Prabhu M.

Kathmandu Univ Med J (KUMJ). 2008 Jan-Mar;6(1):122-7. Review.

PMID:
18604129
19.

National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Aug 28;58(33):921-6.

20.

[Vaccination in patients with cirrhosis].

Loulergue P, Launay O; le groupe GEVACCIM (Groupe d'Etude sur la Vaccination des Sujets Immunodéprimés).

Presse Med. 2009 Jul-Aug;38(7-8):1134-40. doi: 10.1016/j.lpm.2008.11.015. Epub 2009 Jan 29. Review. French.

PMID:
19185447
Items per page

Supplemental Content

Write to the Help Desk